104 related articles for article (PubMed ID: 34976209)
1. Loss of function of GATA3 induces basal-like mammary tumors.
Bai F; Zheng C; Liu X; Chan HL; Liu S; Ma J; Ren S; Zhu WG; Pei XH
Theranostics; 2022; 12(2):720-733. PubMed ID: 34976209
[No Abstract] [Full Text] [Related]
2. GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer.
Wang X; Bai F; Liu X; Peng B; Xu X; Zhang H; Fu L; Zhu WG; Wang B; Pei XH
BMC Biol; 2024 Apr; 22(1):85. PubMed ID: 38627785
[TBL] [Abstract][Full Text] [Related]
3. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
4. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
5. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
[TBL] [Abstract][Full Text] [Related]
6. Arsenic reduces the GATA3 expression associated with an increase in proliferation and migration of mammary epithelial cell line MCF-10A.
Vergara-Gerónimo CA; León-Del-Rio A; Rodríguez-Dorantes M; Camacho-Carranza R; Ostrosky-Wegman P; Salazar AM
Toxicol Appl Pharmacol; 2023 Aug; 472():116573. PubMed ID: 37269932
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 mutations and luminal-basal transformation.
Ng T; Irshad S; Stebbing J
Oncogene; 2013 May; 32(22):2712-4. PubMed ID: 22926516
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
Dib A; Peterson TR; Raducha-Grace L; Zingone A; Zhan F; Hanamura I; Barlogie B; Shaughnessy J; Kuehl WM
Cell Div; 2006 Oct; 1():23. PubMed ID: 17049078
[TBL] [Abstract][Full Text] [Related]
9. Ehf controls mammary alveolar lineage differentiation and is a putative suppressor of breast tumorigenesis.
Nightingale R; Reehorst CM; Vukelic N; Papadopoulos N; Liao Y; Guleria S; Bell C; Vaillant F; Paul S; Luk IY; Dhillon AS; Jenkins LJ; Morrow RJ; Jackling FC; Chand AL; Chisanga D; Chen Y; Williams DS; Anderson RL; Ellis S; Meikle PJ; Shi W; Visvader JE; Pal B; Mariadason JM
Dev Cell; 2024 May; ():. PubMed ID: 38781975
[TBL] [Abstract][Full Text] [Related]
10. Gene of the month: GATA3.
Qiang Z; Jubber I; Lloyd K; Cumberbatch M; Griffin J
J Clin Pathol; 2023 Dec; 76(12):793-797. PubMed ID: 37726118
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas.
Kern JG; Tilston-Lunel AM; Federico A; Ning B; Mueller A; Peppler GB; Stampouloglou E; Cheng N; Johnson RL; Lenburg ME; Beane JE; Monti S; Varelas X
Nat Commun; 2022 Nov; 13(1):7198. PubMed ID: 36443313
[TBL] [Abstract][Full Text] [Related]
12. Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions.
Bertolini I; Perego M; Nefedova Y; Lin C; Milcarek A; Vogel P; Ghosh JC; Kossenkov AV; Altieri DC
J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36892943
[TBL] [Abstract][Full Text] [Related]
13. Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer.
Langille E; Al-Zahrani KN; Ma Z; Liang M; Uuskula-Reimand L; Espin R; Teng K; Malik A; Bergholtz H; Ghamrasni SE; Afiuni-Zadeh S; Tsai R; Alvi S; Elia A; Lü Y; Oh RH; Kozma KJ; Trcka D; Narimatsu M; Liu JC; Nguyen T; Barutcu S; Loganathan SK; Bremner R; Bader GD; Egan SE; Cescon DW; Sørlie T; Wrana JL; Jackson HW; Wilson MD; Witkiewicz AK; Knudsen ES; Pujana MA; Wahl GM; Schramek D
Cancer Discov; 2022 Dec; 12(12):2930-2953. PubMed ID: 36108220
[TBL] [Abstract][Full Text] [Related]
14. A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer.
Zeng J; Singh S; Jiang Y; Casarez E; Atkins KA; Janes KA; Zong H
bioRxiv; 2023 Apr; ():. PubMed ID: 37163037
[TBL] [Abstract][Full Text] [Related]
15. A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression.
Karantza-Wadsworth V; White E
Methods Enzymol; 2008; 446():61-76. PubMed ID: 18603116
[TBL] [Abstract][Full Text] [Related]
16. A transcriptional response to replication stress selectively expands a subset of Brca2-mutant mammary epithelial cells.
Najafabadi MG; Gray GK; Kong LR; Gupta K; Perera D; Naylor H; Brugge JS; Venkitaraman AR; Shehata M
Nat Commun; 2023 Aug; 14(1):5206. PubMed ID: 37626143
[TBL] [Abstract][Full Text] [Related]
17. Proliferative heterogeneity of murine epithelial cells in the adult mammary gland.
Shehata M; Waterhouse PD; Casey AE; Fang H; Hazelwood L; Khokha R
Commun Biol; 2018; 1():111. PubMed ID: 30271991
[TBL] [Abstract][Full Text] [Related]
18. P4HTM: A Novel Downstream Target of GATA3 in Breast Cancer.
DiDonna SC; Nagornyuk A; Adhikari N; Takada M; Takaku M
Res Sq; 2023 Feb; ():. PubMed ID: 36909571
[TBL] [Abstract][Full Text] [Related]
19. Loss of
Brune Z; Li D; Song S; Li DI; Castro I; Rasquinha R; Rice MR; Guo Q; Kampta K; Moss M; Lallo M; Pimenta E; Somerville C; Lapan M; Nelson V; Dos Santos CO; Blanc L; Pruitt K; Barnes BJ
bioRxiv; 2023 May; ():. PubMed ID: 37292919
[TBL] [Abstract][Full Text] [Related]
20. INO80 function is required for mouse mammary gland development, but mutation alone may be insufficient for breast cancer.
Thang NX; Han DW; Park C; Lee H; La H; Yoo S; Lee H; Uhm SJ; Song H; Do JT; Park KS; Choi Y; Hong K
Front Cell Dev Biol; 2023; 11():1253274. PubMed ID: 38020889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
